Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Antimyeloma activity of heat shock protein-90 inhibition

Constantine S. Mitsiades, Nicholas S. Mitsiades, Ciaran J. McMullan, Vassiliki Poulaki, Andrew L. Kung, Faith E. Davies, Gareth Morgan, Masaharu Akiyama, Reshma Shringarpure, Nikhil C. Munshi, Paul G. Richardson, Teru Hideshima, Dharminder Chauhan, Xuesong Gu, Charles Bailey, Marie Joseph, Towia A. Libermann, Neal S. Rosen, Kenneth C. Anderson

Blood (2006) 107 (3): 1092–1100.

https://doi.org/10.1182/blood-2005-03-1158

Published: 2006

Includes: Supplemental data

Journal Articles

PKC412 Is a Multi-Targeting Kinase Inhibitor with Activity Against Multiple Myeloma In Vitro and In Vivo.

Joseph Negri, Nicholas Mitsiades, Qingwei Deng, Zhaoqin Wen, David C. Geer, Ciaran McMullan, Vassiliki Poulaki, Teru Hideshima, Dharminder Chauhan, Thomas Meyer, Nikhil C. Munshi, Paul G. Richardson, Andrew L. Kung, Kenneth C. Anderson, Constantine S. Mitsiades

Blood (2005) 106 (11): 247.

https://doi.org/10.1182/blood.V106.11.247.247

Published: 2005

Journal Articles

NVP-AEW541: A Selective Small Molecule IGF-1R Tyrosine Kinase Inhibitor Is Active Against Multiple Myeloma and Other Hematologic Neoplasias and Solid Tumors.

Nicholas Mitsiades, MD, PhD, Ciaran J. McMullan, Vassiliki Poulaki, MD, PhD, Reshma Shringarpure, PhD, Towia A. Libermann, PhD, Teru Hideshima, MD, PhD, Dharminder Chauhan, PhD, Robert L. Schlossman, MD, Paul G. Richardson, MD, Nikhil C. Munshi, MD, PhD, Carlos Garcia-Echeverria, PhD, Francesco Hoffmann, PhD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD, PhD

Blood (2004) 104 (11): 766.

https://doi.org/10.1182/blood.V104.11.766.766

Published: 2004

Journal Articles

Avicins: A Novel Class of Anti-Myeloma Agents.

Nicholas Mitsiades, MD, PhD, Ciaran J. McMullan, MSc, Vassiliki Poulaki, MD, PhD, Joseph Negri, David C. Geer, MSc, Valsala Haridas, PhD, Nikhil C. Munshi, MD, PhD, Jordan Gutterman, MD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD, PhD

Blood (2004) 104 (11): 3405.

https://doi.org/10.1182/blood.V104.11.3405.3405

Published: 2004

Journal Articles

The mTOR Inhibitor RAD001 (everolimus) Is Active Against Multiple Myeloma Cells In Vitro and in Vivo.

Nicholas Mitsiades, MD, PhD, Ciaran McMullan, MSc, Vassiliki Poulaki, MD, PhD, Joseph Negri, Noopur Raje, MD, Shaji Kumar, MD, Despoina Sikoutri, Teru Hideshima, MD, PhD, Dharminder Chauhan, PhD, Paul G. Richardson, MD, Robert L. Schlossman, MD, Andrew L. Kung, MD, PhD, Heidi Lane, PhD, Nikhil C. Munshi, MD, PhD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD, PhD

Blood (2004) 104 (11): 1496.

https://doi.org/10.1182/blood.V104.11.1496.1496

Published: 2004

Journal Articles

Molecular sequelae of histone deacetylase inhibition in human malignant B cells

Nicholas Mitsiades, Constantine S. Mitsiades, Paul G. Richardson, Ciaran McMullan, Vassiliki Poulaki, Galinos Fanourakis, Robert Schlossman, Dharminder Chauhan, Nikhil C. Munshi, Teru Hideshima, Victoria M. Richon, Paul A. Marks, Kenneth C. Anderson

Blood (2003) 101 (10): 4055–4062.

https://doi.org/10.1182/blood-2002-11-3514

Published: 2003

Journal Articles

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications

Nicholas Mitsiades, Constantine S. Mitsiades, Paul G. Richardson, Vassiliki Poulaki, Yu-Tzu Tai, Dharminder Chauhan, Galinos Fanourakis, Xuesong Gu, Charles Bailey, Marie Joseph, Towia A. Libermann, Robert Schlossman, Nikhil C. Munshi, Teru Hideshima, Kenneth C. Anderson

Blood (2003) 101 (6): 2377–2380.

https://doi.org/10.1182/blood-2002-06-1768

Published: 2003

Journal Articles

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

Nicholas Mitsiades, Constantine S. Mitsiades, Vassiliki Poulaki, Dharminder Chauhan, Paul G. Richardson, Teru Hideshima, Nikhil C. Munshi, Steven P. Treon, Kenneth C. Anderson

Blood (2002) 99 (12): 4525–4530.

https://doi.org/10.1182/blood.V99.12.4525

Published: 2002

Journal Articles

Biologic sequelae of nuclear factor–κB blockade in multiple myeloma: therapeutic applications

Nicholas Mitsiades, Constantine S. Mitsiades, Vassiliki Poulaki, Dharminder Chauhan, Paul G. Richardson, Teru Hideshima, Nikhil Munshi, Steven P. Treon, Kenneth C. Anderson

Blood (2002) 99 (11): 4079–4086.

https://doi.org/10.1182/blood.V99.11.4079

Published: 2002

Journal Articles

Intracellular regulation of tumor necrosis factor–related apoptosis-inducing ligand–induced apoptosis in human multiple myeloma cells

Nicholas Mitsiades, Constantine S. Mitsiades, Vassiliki Poulaki, Kenneth C. Anderson, Steven P. Treon

Blood (2002) 99 (6): 2162–2171.

https://doi.org/10.1182/blood.V99.6.2162

Published: 2002

NARROW

Antimyeloma activity of heat shock protein-90 inhibition

PKC412 Is a Multi-Targeting Kinase Inhibitor with Activity Against Multiple Myeloma In Vitro and In Vivo.

NVP-AEW541: A Selective Small Molecule IGF-1R Tyrosine Kinase Inhibitor Is Active Against Multiple Myeloma and Other Hematologic Neoplasias and Solid Tumors.

Avicins: A Novel Class of Anti-Myeloma Agents.

The mTOR Inhibitor RAD001 (everolimus) Is Active Against Multiple Myeloma Cells In Vitro and in Vivo.

Molecular sequelae of histone deacetylase inhibition in human malignant B cells

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

Biologic sequelae of nuclear factor–κB blockade in multiple myeloma: therapeutic applications

Intracellular regulation of tumor necrosis factor–related apoptosis-inducing ligand–induced apoptosis in human multiple myeloma cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only